Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Leo Swadling, Mariana O. Diniz, Nathalie Schmidt, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 110-117
Open Access | Times Cited: 356
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1418-1423
Open Access | Times Cited: 351
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons, et al.
Science Immunology (2020) Vol. 5, Iss. 54
Open Access | Times Cited: 205
Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers
George Joy, Jessica Artico, Hibba Kurdi, et al.
JACC. Cardiovascular imaging (2021) Vol. 14, Iss. 11, pp. 2155-2166
Open Access | Times Cited: 144
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Rik G.H. Lindeboom, Kaylee B. Worlock, Lisa M. Dratva, et al.
Nature (2024) Vol. 631, Iss. 8019, pp. 189-198
Open Access | Times Cited: 43
Prolonged Stress Causes Depression in Frontline Workers Facing the COVID-19 Pandemic—A Repeated Cross-Sectional Study in a COVID-19 Hub-Hospital in Central Italy
Nicola Magnavita, Paolo Soave, Massimo Antonelli
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 14, pp. 7316-7316
Open Access | Times Cited: 97
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
Charlotte Manisty, Thomas A. Treibel, Melanie P. Jensen, et al.
EBioMedicine (2021) Vol. 65, pp. 103259-103259
Open Access | Times Cited: 68
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
Rishi K Gupta, Joshua Rosenheim, Lucy C. K. Bell, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 10, pp. e508-e517
Open Access | Times Cited: 58
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Gabriella Captur, James Moon, Constantin‐Cristian Topriceanu, et al.
EBioMedicine (2022) Vol. 85, pp. 104293-104293
Open Access | Times Cited: 52
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
Aneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100557-100557
Open Access | Times Cited: 50
HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
Stuart Astbury, Catherine J. Reynolds, David K. Butler, et al.
Immunology (2022) Vol. 166, Iss. 1, pp. 68-77
Open Access | Times Cited: 31
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
Leo Swadling, Mariana O. Diniz, Nathalie Schmidt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32
Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
Ana M. Valdes, James Moon, Amrita Vijay, et al.
EClinicalMedicine (2021) Vol. 34, pp. 100835-100835
Open Access | Times Cited: 27
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Peter A. C. Wing, Nathalie Schmidt, Rory Peters, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011323-e1011323
Open Access | Times Cited: 8
A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study
Emily Jefferson, Christian Cole, Shahzad Mumtaz, et al.
Journal of Medical Internet Research (2022) Vol. 24, Iss. 12, pp. e40035-e40035
Open Access | Times Cited: 11
Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
Leo Swadling, Mala K. Maini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4371-4371
Open Access | Times Cited: 6
Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave
Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 9
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response
Ashley Otter, Abbie Bown, Silvia D’Arcangelo, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection
Rishi K Gupta, Joshua Rosenheim, Lucy C. K. Bell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic
David M. Favara, Karen McAdam, A. Cooke, et al.
Clinical Oncology (2021) Vol. 33, Iss. 10, pp. 667-675
Open Access | Times Cited: 7
Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
Thomas A. Treibel, Charlotte Manisty, Mervyn Andiapen, et al.
The Lancet (2020) Vol. 396, Iss. 10260, pp. 1394-1395
Open Access | Times Cited: 7
Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses
Aneesh Chandran, Joshua Rosenheim, Gayathrie Nageswaran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling
Charlotte Manisty, Thomas A. Treibel, Melanie P. Jensen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 5
An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity
Nathalie Schmidt, Peter A. C. Wing, Rory Peters, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination
Chiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1784-1784
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top